Ardent Health, Inc. (NYSE:ARDT) Given Average Recommendation of “Hold” by Brokerages

Ardent Health, Inc. (NYSE:ARDT) has been assigned a consensus rating of “Hold” from the fourteen ratings firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have given a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $14.2083.

A number of research analysts have commented on ARDT shares. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a research note on Friday, June 12th. UBS Group upped their price target on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Royal Bank Of Canada decreased their price target on Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, March 9th. Leerink Partners decreased their price target on Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a research note on Friday, March 6th. Finally, Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 25th.

Insider Buying and Selling at Ardent Health

In related news, CFO Alfred Lumsdaine acquired 10,000 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $8.81 per share, with a total value of $88,100.00. Following the completion of the transaction, the chief financial officer owned 329,183 shares of the company’s stock, valued at $2,900,102.23. The trade was a 3.13% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.90% of the company’s stock.

Institutional Trading of Ardent Health

A number of large investors have recently modified their holdings of ARDT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Ardent Health by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after acquiring an additional 7,182 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after acquiring an additional 724,841 shares during the period. Jane Street Group LLC increased its position in shares of Ardent Health by 235.1% during the first quarter. Jane Street Group LLC now owns 57,468 shares of the company’s stock worth $790,000 after acquiring an additional 40,318 shares during the period. Acadian Asset Management LLC increased its position in shares of Ardent Health by 574.9% during the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company’s stock worth $550,000 after acquiring an additional 34,276 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Ardent Health by 0.6% during the second quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after acquiring an additional 1,769 shares during the period.

Ardent Health Stock Down 1.7%

NYSE:ARDT opened at $9.11 on Thursday. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The stock’s fifty day moving average is $9.51 and its two-hundred day moving average is $9.13. Ardent Health has a 52 week low of $7.71 and a 52 week high of $15.48. The stock has a market capitalization of $1.31 billion, a price-to-earnings ratio of 9.58, a price-to-earnings-growth ratio of 2.10 and a beta of 0.84.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Research analysts anticipate that Ardent Health will post 1.11 EPS for the current year.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.